Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector

This paper demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade Related Intellectual Property Rights System) in 1995 served to open up new economic opportunities and constraints in the wake of which the winners and losers were selected as a function of the dynamic firm capabilities most appropriate for the new market environment.

[1]  J. R. Moore,et al.  The theory of the growth of the firm twenty-five years after , 1960 .

[2]  R. Rumelt Towards a Strategic Theory of the Firm , 1984 .

[3]  S. Winter,et al.  An Evolutionary Theory of Economic Change.by Richard R. Nelson; Sidney G. Winter , 1987 .

[4]  James M. Utterback,et al.  Mastering the Dynamics of Innovation , 1996 .

[5]  D. Teece,et al.  DYNAMIC CAPABILITIES AND STRATEGIC MANAGEMENT , 1997 .

[6]  D. Teece Capturing Value from Knowledge Assets: The New Economy, Markets for Know-How, and Intangible Assets , 1998 .

[7]  Kathleen M. Eisenhardt,et al.  DYNAMIC CAPABILITIES, WHAT ARE THEY? , 2000 .

[8]  S. Ramani,et al.  A statistical examination of the integration of biotechnology in the Indian pharmaceutical sector , 2001 .

[9]  S. Ramani Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms , 2002 .

[10]  S. Winter Understanding dynamic capabilities , 2003 .

[11]  D. Kale Re-developing knowledge creation capability: Innovating in Indian pharmaceutical industry under the TRIPS regime , 2005 .

[12]  P. Sampath Indian Pharma Within Global Reach , 2006 .

[13]  Indian Pharma within Global Reach? Working Paper Series Indian Pharma within Global Reach? Forthcoming in Unu-merit Working Papers , 2006 .

[14]  J. Pradhan New Policy Regime and Small Pharmaceutical Firms in India , 2007 .

[15]  Steve Little,et al.  From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry , 2007, Technol. Anal. Strateg. Manag..

[16]  Des Spence The bitterest pill , 2007, BMJ : British Medical Journal.

[17]  Geert Duysters,et al.  Serving low-income markets: Rethinking Multinational Corporations’ Strategies , 2008 .